Authors' response to letter regarding the WA Regulatory Scheme for Stimulants

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Authors' response to letter to the editor.

We thank Drs. Mandal and Goel for their interest in our work, but we disagree with their interpretation of the literature compared with our findings. While Waldert and associates did indeed find a correlation between a longer delay to nephroureterectomy (NUx) and more advanced stage, they did not report metastasis-free survival. Moreover, they found no difference in cancer-specific survival. Th...

متن کامل

Letter to the Editor: Authors' Response.

Thank you for the opportunity to respond to the concerns of Dr Reneman and colleagues about our paper, Kersnovske et al. [13]. Dr Reneman and colleagues have raised two issues that we address below. Their first concern relates to the use of experts for the purpose of validation. We assume the authors are not concerned with the use of experts as a method of content validation, per se, as this is...

متن کامل

Authors' Response to Letter Regarding "Questionable validity of the catheter-associated urinary tract infection metric used for value-based purchasing".

Possible Conflict of Interest: Kevin T. Kavanagh, MD, MS has served as a non-paid member of the 2014 Centers for Medicare and Medicaid’s Technical Expert Panel for Hospital-Acquired Conditions. Dr. Kavanagh has received partial financial support for attendance of conferences from Consumer Union, the Dept. of Health and Human Services and the National Quality Forum. The remainder of the authors ...

متن کامل

Response letter regarding the letter to the editors by Brown et al.

We read with interest the letter by Brown and colleagues, which focuses on our model’s assumptions regarding duration of cross-protection against non-vaccine HPV types (20, 30, 50 y and lifetime). Brown et al. begin by highlighting an article reviewing cross protection in different vaccine trials by Malag on et al., which suggests that AS04-adjuvanted HPV16/18 (bHPV, CervarixTM) vaccine-mediate...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Australian and New Zealand Journal of Public Health

سال: 2008

ISSN: 1326-0200

DOI: 10.1111/j.1753-6405.2008.00263.x